Award
Award #75N93026D00017
Multi-year IDV Awarded to Research Triangle Institute for Antimicrobial Activity Assessment
Buyer
National Institutes of Health
Award Amount
$2,500.00
Ceiling
$2,500.00
Awarded
September 30, 2026
Period of Performance
Sep 30, 2026 – Sep 29, 2036
Identifier
75N93026D00017
NAICS
541714
This indefinite delivery vehicle (IDV) contract was recently awarded to Research Triangle Institute, a research organization known for scientific and technological solutions, to conduct in vitro assessments of antimicrobial activity. The contract involves a comprehensive scientific evaluation aimed at advancing understanding and development of antimicrobial agents, which is critical for public health and pharmaceutical industries. As a multi-year agreement spanning a decade, it highlights the agency's commitment to long-term research in combating microbial threats. The work scope includes laboratory-based testing and analysis to determine the efficacy of antimicrobial substances. The contract was awarded through a non-competitive process, indicating a sole-source acquisition likely due to the specialized expertise of the recipient. While no contract vehicle or subcontractors are specified, this award supports ongoing efforts to enhance antimicrobial research capabilities and aligns with broader government health initiatives.
Description
IN VITRO ASSESSMENT OF ANTIMICROBIAL ACTIVITY (IVAAA)